Trial Profile

A clinical trial with sub-cutaneous Plasminogen in patients with diabetic foot ulcers

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 24 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Plasminogen (Primary)
Indications Diabetic foot ulcer
Focus Therapeutic Use

Most Recent Events

28 Mar 2018 According to a ProMetic Life Sciences media release, study is being conducted in one study center in Sweden, under the supervision of Dr. Jan Apelqvist,from the Department of Endocrinology, Division of Clinical Sciences at Skane University Hospital in Malmo, Sweden.
26 Feb 2018 New trial record
20 Feb 2018 According to a ProMetic Life Sciences media release, interim clinical data readouts are expected later this year.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com